By maintaining cancer stem cell populations and promoting epithelial–mesenchymal transition (EMT), OCT4 enables tumor cells to evade standard therapies and acquire more invasive and treatment-resistant characteristics. This evidence concerns the gene POU5F1 and neoplasm.